(Press-News.org) Supplementing standard opioid addiction treatment with Mindfulness Oriented Recovery Enhancement (MORE) — an intervention that incorporates mindfulness training, savoring skills, and cognitive reappraisal — cuts program dropout rates by 59 percent and relapses by 42 percent, according to Rutgers-led research.
These trial results come from Rutgers Health amid unprecedented opioid abuse. An estimated 10 million Americans misuse opioids or have opioid use disorder, while annual overdose deaths have exceeded 80,000.
Treatment with methadone or buprenorphine – alone or in combination with cognitive behavioral therapy – is imperfect. Half of all people drop out of treatment within a year, and half of all people who continue treatment keep using opioids.
“Better treatment protocols could save thousands of lives per year, and the data we have from our pilot study and this phase II trial suggest mindfulness training may create a genuinely better treatment protocol,” said Nina Cooperman, an associate professor of psychiatry at Rutgers Robert Wood Johnson Medical School and first author of the study published in JAMA Psychiatry.
Mindfulness training teaches people to focus on the present moment, without judgment, and on sensory inputs such as the feeling of breathing in and out. Previous studies demonstrating that such training can prevent addiction to opioid pain medication led Cooperman’s team to ask whether similar techniques could help people who already have an opioid use disorder.
A small pilot study found that mindfulness training combined with methadone treatment produced good outcomes. The pilot’s success paved the way for this larger study, which, in turn, has justified two large-scale studies that could change standards of care.
The current trial provided eight two-hour sessions to 77 of 154 patients in methadone treatment for opioid use disorder.
“Opioid use disorder changes your brain so that opioid use becomes the only thing that feels rewarding. MORE helps people retrain themselves to find healthy experiences rewarding again by focusing mindfully on the taste of a meal, the beauty of a landscape or the smell of a flower,” said Cooperman, who added the program literally includes observing and smelling roses during sessions.
Mindfulness training also gives people another tool for handling cravings.
“Cognitive behavioral therapy, which is common in treatment programs, teaches people to reframe their thoughts and distract themselves from cravings,” Cooperman said. “Mindfulness training teaches them to stay present with the craving and notice that they pass. Both strategies can work, so both are valuable.”
The success of mindfulness training in Cooperman’s study may stem from its ability to help patients manage pain. Most patients began the study with significant chronic pain — and, thus, a strong incentive to use pain-killing opioids — but patients who received MORE reported a 10 percent reduction in pain over the 16 weeks of the study.
Looking forward, Cooperman and her team are working on larger studies, which are designed to provide further evidence for the efficacy of MORE and to optimize protocols for use in the real world.
“We still have lots of open questions. How can we train clinicians to implement MORE in treatment programs? What is the best structure for implementing MORE—in-person or virtual? Our current research is working to answer some of these questions,” Cooperman said. “The findings from this study suggest MORE really can improve outcomes for a lot of people in substance abuse treatment.”
END
Mindfulness training enhances opioid addiction treatment
2024-05-06
ELSE PRESS RELEASES FROM THIS DATE:
Using advanced genetic techniques, scientists create mice with traits of Tourette disorder
2024-05-06
In research that may be a step forward toward finding personalized treatments for Tourette disorder, scientists at Rutgers University–New Brunswick have bred mice that exhibit some of the same behaviors and brain abnormalities seen in humans with the disorder.
As reported in the Proceedings of the National Academy of Sciences, the researchers, using a technique known as CRISPR/Cas9 DNA editing that selectively modifies the DNA of living organisms, inserted the same genetic mutations found in humans with Tourette disorder into the corresponding genes in mouse embryos. After the mice were born, the scientists observed their behavior compared with littermates without the ...
3D video conferencing tool lets remote user control the view
2024-05-06
ITHACA, N.Y. -- Collaborating on a physical object when two people aren’t in the same room can be extremely challenging, but a new remote conferencing system allows the remote user to manipulate a view of the scene in 3D, to assist in complex tasks like debugging complicated hardware.
The system, called SharedNeRF, combines two graphics rendering techniques – one that is slow and photorealistic, and another that is instantaneous but less precise – to help the remote user experience ...
The Ottawa Hospital is expanding life-saving biotherapeutics research and manufacturing to its new campus thanks to $59 million grant
2024-05-06
The Ottawa Hospital is receiving $59 million to boost Canada’s capacity to develop and manufacture life-saving biotherapeutics, including vaccines, gene therapies and cell therapies. Most of the funding ($47 million) will support the construction and operation of a world-class biomanufacturing facility at The Ottawa Hospital’s new campus, while the remainder will enable harmonization and cooperation across six Canadian biomanufacturing facilities.
The funding is part of a $115 million investment from the Government of Canada in the Canadian Pandemic ...
Early neurodevelopmental assessments for predicting long-term outcomes in infants at high risk of cerebral palsy
2024-05-06
About The Study: The results of this study support the potential to identify cerebral palsy and its severity as early as corrected age 3 to 4 months through early neurodevelopmental assessments, but the role of these tests is limited in identifying cognitive and neurodevelopmental impairments.
Authors: Abdul Razak, M.D., of Monash University in Melbourne, Australia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.9053)
Editor’s ...
Snowfall and drought: $4.8 million field campaign will improve forecasts in western US, led by U-M
2024-05-06
Images
A new science expedition in Yampa Valley, Colorado, will improve forecasts of snowfall and estimates of how climate change will impact snowpack and water availability in the western U.S. mountains, funded with $4.8M from the National Science Foundation.
The field campaign, led by the University of Michigan, brings together scientists from the University of Washington, University of Wisconsin, University of Utah, Colorado State University and Stony Brook University. The team will use an extensive suite of radars and snow-sampling instruments to measure the size and shape of snowflakes and aerosols. ...
SwRI Workbench for Offline Robotics Development™ (SWORD™) launched at Automate 2024
2024-05-06
SAN ANTONIO — May 6, 2024 – Southwest Research Institute is simplifying robotics programming with a new toolkit that embeds computer-aided design (CAD) into robotics motion planning, modeling and execution. The SwRI Workbench for Offline Robotics Development™ (SWORD™) features a user-friendly graphical interface to demystify the fundamental coding required in robot operating system (ROS) application development.
Informed by the Institute’s role in supporting the ROS-Industrial community, SwRI developed ...
Science doesn't understand how ice forms (video)
2024-05-06
WASHINGTON, May 6, 2024 — This video contains incredible macro footage of supercooled water droplets nucleating ice. All George wanted to do was make a crystal-clear ice cube. Instead, he ended up rediscovering dendritic crystal growth, a beautiful phenomenon first described in the 17th century. You’ll never look at your freezer the same way again. https://youtu.be/24TB1vPuzIU?feature=shared
Reactions is a video series produced by the American Chemical Society and PBS Digital Studios. Subscribe to Reactions at http://bit.ly/ACSReactions and ...
Study reveals APOE4 gene duplication as a new genetic form of Alzheimer's disease
2024-05-06
Researchers from the Research Area on Neurological Diseases, Neuroscience, and Mental Health at the Sant Pau Research Institute, led by Dr. Juan Fortea, Director of the Memory Unit of the Neurology Service at the same hospital, have found that over 95% of individuals over 65 years old who have two copies of the APOE4 gene -APOE4 homozygotes- show biological characteristics of Alzheimer's pathology in the brain or biomarkers of this disease in cerebrospinal fluid and PET scans.
The study, published today in Nature Medicine, also concludes that those individuals homozygous for APOE4 also develop ...
Study highlights key predictors of adolescent substance use; special issue of the American Journal of Psychiatry focuses on substance use disorders
2024-05-06
NEW YORK, May 6, 2024 – New research, published online today in the American Journal of Psychiatry, examined a broad range of potential predictors of substance use among adolescents and found sociodemographic variables were the most robust predictors of substance use initiation.
The study is part of a special issue of the journal highlighting advances in understanding the neurobiology and sociodemographic underpinnings of substance use disorders and how this understanding has advanced recognition and treatment. Several authors discussed this work today at a special briefing during the 2024 Annual Meeting of the American Psychiatric ...
Racial and ethnic disparities in initiation of direct oral anticoagulants among Medicare beneficiaries
2024-05-06
About The Study: In this cohort study of Medicare patients with atrial fibrillation, Black and Hispanic patients were less likely to initiate direct oral anticoagulants for atrial fibrillation, although these differences diminished over time. Identifying the factors behind these early disparities is crucial for ensuring equitable access to novel therapies as they emerge for Black and Hispanic populations.
Corresponding Authors: To contact the corresponding authors, email Kamika R. Reynolds, M.S., Ph.D. (kreynolds@ifh.rutgers.edu) and Chintan ...